Adrien Inoubli

Dr. Adrien Inoubli has been Regional Adviser for Medical Products Regulation for 3 years in the WHO Regional Office for South-East Asia. In this position, he has been providing support to member states in strengthening their regulatory systems and has also acted as secretariat for SEARN, the South-East Asia Regulatory Network. Before joining WHO, he worked on regulatory processes, compassionate use, clinical trials, and marketing authorizations for the UK and French medicines agencies. His last position was representing France in the EMA’s pharmacovigilance committee, the PRAC.

SECURE Webinar 19: Enhancing the Quality and Safety of Medicine in Southeast Asia

COVID-19 posed a major challenge to the global health agenda, with pharmaceutical manufacturers shifting their production and distribution processes to rapidly respond to escalating demands for vaccines and medical products. The pandemic also revitalized the importance of sound pharmacovigilance (PV) systems and national regulatory authorities (NRA) to ensure the safety, quality, and efficacy of vaccines and drugs.